Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity.
- Shares Purchased: 2,062,463 ordinary shares
- Purchase Date: August 29, 2025
- Price Range: 359.10p (Low) to 364.40p (High)
- Volume Weighted Average Price: 362.5142p
- Post-Transaction Share Capital: 8,959,221,411 ordinary shares
- Treasury Shares Held: 3,880,205
- Voting Shares Outstanding: 8,955,341,206
Material Changes
The primary material change is the reduction of outstanding shares through the cancellation of 2,062,463 shares purchased under the second tranche of the buyback programme announced on July 31, 2025. This transaction reduces the total number of shares with voting rights.
Guidance, Outlook, and Risks
The filing contains no financial guidance, forward-looking outlook, or discussion of risks and contingencies. It is a regulatory disclosure of a completed share transaction. The company notes that a full breakdown of individual trades is available via the London Stock Exchange to comply with the Market Abuse Regulation.
Key Facts for Investor Verification
- Verify the total number of shares purchased under the second tranche of the buyback programme to date.
- Confirm the updated number of voting shares (8,955,341,206) for disclosure threshold calculations under FCA rules.
- Review the full trade breakdown at the provided London Stock Exchange link for granular pricing data.
- Check the company's website for the latest treasury share count and total share capital updates.